Anavex Life Sciences Corp.

Anavex Life Sciences Corp.

Anavex Life Sciences Corp.

Overview
Date Founded

2004

Headquarters

51 West 52nd Street, 7th Floor, New York, NY, 10019, USA

Type of Company

Public

Employees (Worldwide)

13

Industries

Biotechnology
Pharmaceuticals

Company Description

Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. The company was founded by Harvey Lalach and Athanasios Skarpelos on January 23, 2004 and is headquartered in New York, NY.

Contact Data
Trying to get in touch with decision makers at Anavex Life Sciences Corp.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

President, Chief Executive Officer, Chief Financial Officer, Secretary & Treasurer

Chief Medical Officer

Principal Financial Officer, Principal Accounting Officer & Treasurer

Senior Vice President of Regulatory Affairs

Senior Vice President, Operations

Vice President-Clinical Operations

Vice President of Business Development & Scientific Strategy

Board of Directors

Founder at Anavex Life Sciences Corp.

Head-Internal Audit & Risk Management at Ströer SE & Co. KGaA

President, Chief Executive Officer, Chief Financial Officer, Secretary & Treasurer at Anavex Life Sciences Corp.

Member, Board of Directors at Anavex Life Sciences Corp.

Member, Board of Directors at Anavex Life Sciences Corp.

Paths to Anavex Life Sciences Corp.
Potential Connections via
Relationship Science
You
Anavex Life Sciences Corp.
Owners & Shareholders
Details Hidden

Knoll Capital Management manages a long/short US equity fund that invests primarily in the stocks of small-cap companies in the health technology sector. The firm employs a fundamental, bottom-up individual stock selection process. They employ a fundamental short selling strategy. Knoll Capital Management's investment approach is based on disciplined risk management with sector/position limits, price targets and stop losses. The firm does not use arbitrage, futures or pairs trading. Their use of puts and calls is limited

Details Hidden

Knoll Capital Management manages a long/short US equity fund that invests primarily in the stocks of small-cap companies in the health technology sector. The firm employs a fundamental, bottom-up individual stock selection process. They employ a fundamental short selling strategy. Knoll Capital Management's investment approach is based on disciplined risk management with sector/position limits, price targets and stop losses. The firm does not use arbitrage, futures or pairs trading. Their use of puts and calls is limited

Recent Transactions
Details Hidden

Anavex Life Sciences Corp. raised money in a private placement transaction

Details Hidden

Anavex Life Sciences Corp. raised money in a private placement transaction

Details Hidden

Anavex Life Sciences Corp. raised money in a private placement transaction

Transaction Advisors
Investment Advisor

Advised onAnavex Life Sciences Corp. raised money in a private placement transaction

Advisors & Consultants
Publicist

Professional at River East Investor Relations LLC

Publicist

Professional at Dobson Media Group

Publicist

Founder at CoreIR

Key Stats and Financials As of 2018
Market Capitalization
$147M
Total Enterprise Value
$99M
Earnings Per Share
$-0.39
Revenue
$0
Net Profit
$-17.4M
EBITDA
$-19.3M
Total Debt
$0
Total Equity
$20.5M
TEVNet Income
-5.67x
Debt TEV
0x
Three Year Compounded Annual Growth Rate Of Revenue
0%
Five Year Compounded Annual Growth Rate Of Revenue
0%
Suppliers
Government of Israel Government | TA

Competitors
Merck & Co., Inc. Pharmaceuticals - Kenilworth, NJ

Merck & Co., Inc. , d.b.a. Merck Sharp & Dohme, MSD outside the United States and Canada, is an American pharmaceutical company and is one of the largest pharmaceutical companies in the world.

Johnson & Johnson Pharmaceuticals - New Brunswick, New Jersey

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Allergan Plc Pharmaceuticals - Dublin, DU

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Anavex Life Sciences Corp.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Anavex Life Sciences Corp.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Anavex Life Sciences Corp..